1. Home
  2. LRE vs RKTO Comparison

LRE vs RKTO Comparison

Compare LRE & RKTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lead Real Estate Co. Ltd

LRE

Lead Real Estate Co. Ltd

HOLD

Current Price

$1.33

Market Cap

17.7M

Sector

N/A

ML Signal

HOLD

Logo Rocket One Inc. Common Stock

RKTO

Rocket One Inc. Common Stock

N/A

Current Price

$0.76

Market Cap

18.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LRE
RKTO
Founded
2001
N/A
Country
Japan
United States
Employees
N/A
3
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
18.9M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
LRE
RKTO
Price
$1.33
$0.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.9K
5.2M
Earning Date
07-30-2015
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.70
52 Week High
$2.86
$1.19

Technical Indicators

Market Signals
Indicator
LRE
RKTO
Relative Strength Index (RSI) 42.20 42.06
Support Level $1.20 $0.78
Resistance Level $1.38 $0.84
Average True Range (ATR) 0.07 0.06
MACD -0.01 0.00
Stochastic Oscillator 20.87 51.51

Price Performance

Historical Comparison
LRE
RKTO

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About RKTO Rocket One Inc. Common Stock

Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.

Share on Social Networks: